C. Pope et al., POSSIBLE INVOLVEMENT OF A NEUROTROPHIC FACTOR DURING THE EARLY STAGESOF ORGANOPHOSPHATE-INDUCED DELAYED NEUROTOXICITY, Toxicology letters, 75(1-3), 1995, pp. 111-117
Little is known regarding early biochemical events in organophosphate-
induced delayed neurotoxicity (OPIDN) except for the essential inhibit
ion of neurotoxic esterase (NTE). We hypothesized that a trophic facto
r may be produced in situ shortly after exposure to the OF which parti
cipates in the progression of OPIDN. To bioassay for such a growth-mod
ulating factor(s), we treated chickens with the neuropathic agents dii
sopropylfluorophosphate (DFP) or cyclic phenyl saligenin phosphate (PS
P), with or without phenylmethylsulfonyl fluoride (PMSF, a chemical wh
ich markedly modifies OPIDN). Soluble extracts of cervical spinal cord
(a region of the nervous system which degenerates with OPIDN) were co
llected 24 h later and these were incubated with human neuroblastoma S
Y5Y cells in culture. The cells were allowed to grow for another 6 day
s and observed for changes in morphology and growth. After 3 days in c
ulture, tissue extracts from OF-treated chickens caused SY5Y cells to
begin to elongate and extend processes (neurites), similar to cells tr
eated with nerve growth factor(1 mu g/ml). Extracts from chickens not
receiving OP had no or minimal effects on cell morphology. In addition
, extracts from chickens in which OPIDN was prevented by pretreatment
with PMSF did not cause the marked extension of cell processes exhibit
ed after exposure of SY5Y cells to extracts from chickens given regime
ns known to cause OPIDN. In parallel-treated animals, DFP and PSP caus
ed clinical dysfunction characteristic of OPIDN, PMSF posttreatment ma
rkedly amplified the clinical deficits and PMSF pretreatment prevented
OPIDN. In vivo DFP treatment also caused a marked reduction in the ac
tivity of the growth-related enzyme ornithine decarboxylase (ODC) in s
pinal cord but DFP was without effect on ODC activity in vitro (up to
1 mM final concentration), Characterization of this growth-modulating
factor(s) may aid in the elucidation of pathological mechanisms of OPI
DN.